9999999997-13-012065.txt : 20130725 9999999997-13-012065.hdr.sgml : 20130725 20130725092433 ACCESSION NUMBER: 9999999997-13-012065 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130725 DATE AS OF CHANGE: 20130725 20130725 20130725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Conatus Pharmaceuticals Inc CENTRAL INDEX KEY: 0001383701 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203183915 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-189305 FILM NUMBER: 13985143 BUSINESS ADDRESS: STREET 1: 4365 EXECUTIVE DRIVE STREET 2: Suite 200 CITY: San Diego STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 558-8130 MAIL ADDRESS: STREET 1: 4365 EXECUTIVE DRIVE STREET 2: Suite 200 CITY: San Diego STATE: CA ZIP: 92121 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C4P(#`@;V)J#3P\+TQI;F5AF4@-C,O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(.)-@M@<0G.08F1H:#(%D&1G3B/^.D/P`!!@"TO0;D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HV,B`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``*>+@94P,@` MDN5H0!9C@6(&AAL,W`R<_PU:%D"5RAE":*9UR(H-A2"BC,H``08`,`X&.0T* M96YD7!E+U!A9V4^/@UE;F1O8FH--3,@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I95M4W7>(#&/TILVVQ?*Z7&]S MPNB\S7??"$\T7;P\Y>@+D.OBJ:UJ^KVO1"IS=>7JA+K!Y=CI'\MEM2K*-;TO MRNNR*<+WK*B;=KK):G?D_AG0;==%^CGK'812=/[\HP4XB_HY1UP!G,N\:C?- M@S&6_$N!T4B2Q,V`(LK=G,+;0B4W1%_9@2Z7L?.';^[EOI?1>'BPD3II$12G+`S`$Z8*E M2^S76!]B^KWM]]X>8AS0)+(AJ+X!:$\E$8+AJF!5?7-4A,/?0-RY3N&RA@\( MP9+4$!ZG\*D[YQ#5`P1@X"'[3HH1`"\`UF,PTIWF;6;087&@DRG:$]]4XYH@ M!V2=OHLW:A`57=)8P@WB2$2"A402@@[,.(#U(S(6&)]PDP<$?*!)8X$IB"5, MPJ$\,MV;E"!#S"/24J!?Q[%_2;]ZGWZ9.8]^WV1>>81Y+3M-O-*>)-XS.=?] MJ?W'G"O90)_`*&#C=O24M3R;8'93P??>5/P._+M`#/V[`IN-WICW M@UBD7,Z#+5!S'Q"9?S5X3K&>$5X:;V#+Z-$!@-I>LP!EYWBF^E2O;YEK_F M6QE=T5B@4/_O&TO(V&R_/I[?T]XA2@6!L_^8;H^)I]OCXNCVMP`#`(>V M?'<-"F5N9'-TKP\%R^ M\QWJ?3$Z_BC>OCV^'%^<"B7>O7M_.A:CX_&U$K-G6!#/L]7HN"B4T*)X&&DC M`@7+\)LKD:I,YHDHEB-/^,5?(R5-!"^+>34_NT1=M7YM]0EC956 M4JE0%#,XFD($AL79M?][\6&D M4(G"_:G,LSY+PX:E2AG:QX,7.#62:=(\'$Y*O#,_B+WQS=6%'X1>@1,:T3() MB)/)J:#I;[Y6WOAG/XB\D\E/?K57C'_%E4L_R.!A>#OMI`=-26+2Q"8Y1,\Z$L)CV1C&4>-RTC M[ZY.*1I7`@-S=0))5-ZDCB?%2]`JQVMR[N?\BCCZ4!8.5][J=]R#!:FKU8WTRL-W0NI9R3_:V8&=.R(%?14Z$Q<3D^0G[L M.Z`S&?7F+ZOSEWY#%>967&L9YTW?QA#$]0KMFF[]T"-4/6/-B8^^UMXCO7E" M+Y:^#KWI#(?W?L22N*5$!VAY2G#DW1?X)+TS$):,S\-\X@@KD9$>\D37])/( MW#1=.4>#R1JR`XT4$W1/BC#D",=2V;`&S'5A6,UUEHMOAD$RJ]:[^Q-;!^AS_!`T"RF2X1T`S8,LU('D%_P_0"LNYCP+8T#7EXL=V8;[W4\(R`8]1 M#V`F(%AX;B#PJ7??%%H11-LU\$R.B3O:_=4WZE"!J\A180IIA7#9G@)599M* MC$WE$`&0ZA8+Z"8-Q(TS=6A)A2Z1T*VSR/I]@3018BWG7H;"=TV5`N(0);)GKE1.94WSJ M#)4V3:2.I8GNEE8A)AF76Y)KYC'F@THYL??J@##F`%ZC(.U;'@+''D'2BT_$-^09+1[!/?8&%N0UID.. M*?E2Q+'YY(&&NT\^/&D8T?"H8^*I7ZG^NW1W%WL4&\D]#@W:T+-C$7K9B"1C M&49TR"--Z\Q2L+;---5]:L6%6D=EM29)-GHM-KN[9KNB/$&&OOHAE.2\MG]F M4[CFTB5#ZDXHA0LB(0>-X-UL.S4GW&^XVH\$*OCB_"+5NWEE+*[RYD;BT`-C M9.[JLA,T%$;9"@^-M)":176+`_?6+_Y^VZRM>:3EN]JUGI9*UC3J\04!OU@( MK-XU4?V=[6"VCRYL,T4.<'V/6QB0`Q`9B6]@CMT1]R]*;):B216-UK@MEVX' MM11\3QPRMTUH4\FBFI*:CSWX3?<;)]>]_:3^R&'9H7Z2O=9/7I_.;F,/3#HQ<1].09@,!="H3@`/0-$Y6U^`]D""),:7JB4U'_RO^LP^`#()&:YT M'>VUYRU%B-%I#*QN7]3Y3[O2ZJI/R%3F:>#:36=M'9$PF&1 MZ+]7U]"D#UUX#5^4_]!-"_)GR0UPUKIGMPKGUKO$=$I!/Y3?S6.%+:[EK/?3 MU=2W6+@#)5$[NO_;Z0/73N?T-9'RC&Z6]]OZ:@D+1M>0><7UCBM)[8I&V2&@ MI,,HZ')L1R0?%`F[1-,1T<,BP[@.AW$==G'=$8F'15RHM?GNB/DOW']6C/X5 M8``)'22K#0IE;F1S=')E86T-96YD;V)J#34U(#`@;V)J#3P\+T9I;'1E+V!-+B@J`=('@-@H);4X&4A_`>+,\I("H#AC`I`MDI0-9H/4 MB62'!#D#V1U`-E]):@5(C,$YOZ"R*#,]HT3!T-+24L$Q)3\I52&XLK@D-;=8 MP3,O.;^H(+\HL20U!:@6:@<(\+L7)58JN"?FYB8J&.D9D>AR(@`H+"&LSR'@ M,&(4.X\00X#DTJ(R*).1R9B!`2#``$G&."\-"F5N9'-T7!E+T]B:E-T;3X^TL5:5H4D"ED)_KXWF2UM'SK\0"7$77OL8_LX M3E101;5039*4&A+\C@6554,QHH!@JA,"8QH$!C&BI*9$)&IJ1(4Y$5DC%8F_ M`@0N`"F0$0D4,[(JB+$&%Y%8D<+$)3()<4(V2@R>H)/!DS+1O*#4%0EXBD4$ M/,4ZF!JU+DC`*[%=`:]4)@&OK`1'P@X+)0$OH5/`2RG1?*K45*3@55A$P:MP M'$R-55.0@E=CTPI>73(I>#7$*'@-#"AX#3K/SL(5]!6T"=?MF+OI9LP9*O_N M6.>7Z2J_4@R;_C%_:0=HGD?V0]N%BX=VG,+E87\<<_AX:/=C^_36'/OAHAU^-3]U]YB;PWK^=PGYOUN? MN\=#E[VIY-/=7]N+P-OQJNQ6Q:VJ6RW=:G*K ME5NMW6KCVWA'EF\K^KJB[ROZPJ)O+/K*HN\L^M*B;XU]:_S.-^9;8]\:^];8 MM\:^-?:ML6^-?6OB6Q/?FKSS-'UKXEL3WYK\T]I/`08`,<3^W0T*96YDFMC.60B/SX*/'@Z>&UP;65T82!X M;6QN#IX;7!T:STB061O8F4@6$U0($-O M&UP M.DUE=&%D871A1&%T93X*("`@("`@("`@/'AM<#I#&UP34TZ&UP34TZ&UL;G,Z<&1F>#TB:'1T<#HO+VYS+F%D M;V)E+F-O;2]P9&9X+S$N,R\B/@H@("`@("`@("`\<&1F>#I3;W5R8V5-;V1I M9FEE9#Y$.C(P,3,P-S(U,3(T.#,P/"]P9&9X.E-O=7)C94UO9&EF:65D/@H@ M("`@("`@("`\<&1F>#I#;VUP86YY/E-E8W5R:71I97,@86YD($5X:&%N9V4@ M0V]M;6ES#I#;VUP86YY/@H@("`@("`@("`\<&1F>#I#;VUM M96YT#I#;VUM96YT7!E+T]B:E-T;3X^T@B#H>=J)ZR!.)#,#^O8[740\ M>`OA_[^DG@/"8E&L8CBS9-'GQ9JO5W+!9P<2;]F!FN#_]J;=(]M3'\4&2QZT M,["YG[7[)1A*U@_Q%!72(4VM#I2U7R6J"F?E%.?85&J,]0AQ]$REDZM>N-,! M=NWW5E](0.%$P8D%CBPF+[9L/D'-"]H)F]A3D@QW-#CP8SO1\ABH]/J>H_24 M''NR9-X@5=9-A?ER^2?``%'C3Q,-"F5N9'-T